First GLP-1 tablet for weight management approved in the UK disrupts obesity treatment options

Scotland-based health regulators have authorised orforglipron, a first-of-its-kind daily GLP-1 tablet, promising new options for adults with obesity and type 2 diabetes in the UK, subject to further NHS evaluation. Scotland-based health regulators have authorised a new daily weight-loss tablet…













